World Bulletin / News Desk
Taking aspirin daily may help protect against cancer but the effect seems weaker than previously thought, according to a U.S. study that included a decade's worth of data from more than 100,000 people.
"News about the cancer potential of aspirin use has been really encouraging lately," said Michael Thunof the American Cancer Society, who worked on the study that appeared in the Journal of the National Cancer Institute.
"Things are moving forward, but it is still a work in progress," he said.
Medical guidelines in the United states already urge people to take low doses of aspirin to prevent heart disease if the predicted benefits outweigh the risk of side effects, or if they have already suffered a heart attack.
However, whether those recommendations should be broadened to include cancer prevention remains up in the air.
Earlier this year, an analysis of previous clinical trials showed that people on aspirin were less likely to die of cancer than those not on the medication, with a 37 percent drop in cancer deaths observed from five years onwards.
The new report is based on data from more than 100,000 men and women, most over 60 and all of them non-smokers.
People who said they took daily aspirin, whether "baby" or adult strength, had a 16 percent lower risk of dying from cancer than non-users overall, Thun and his colleagues found.
For men, the difference came out to 103 fewer cancer deaths a year per 100,000 people. For women, the number was 42.
The effect was strongest for gastrointestinal cancer, such as colon cancer and stomach cancer.
Because the study wasn't a clinical trial, it's hard to know if the findings can be chalked up to aspirin or if something else is at play. But Thun said they would favor broadening the aspirin guidelines to include cancer prevention based on an individual risk-benefit assessment.
Other researchers are more sceptical. Kausik Ray of St. George's University of London, who has studied aspirin, said the new study did not look at overall death rates or side effects such as serious stomach bleeds.
Earlier this year, Ray's team published an analysis of previous aspirin trials showing the medication did not prevent deaths from heart disease or cancer, and was likely to cause more harm than good.
One of the problems with the new study, as well as with previous aspirin trials, is something called detection bias, he said. For instance, if somebody develops stomach bleeding from aspirin, they are likely to have their bowels checked by a doctor. This may result in finding and removing tumors or pre-cancerous polyps, which could prolong the patient's life.
So far, most aspirin trials have been designed to test its effect on heart disease. Ray called for trials that specifically check people for new cancers at given intervals to weed out the selection bias marring previous research.
The incursion largely follows water currents north from the Red Sea. Already more than 700 non-indigenous species have populated the Mediterranean
Joji Morishita, Japan's commissioner to the International Whaling Commission, said the new proposal is Tokyo's latest attempt to pursue sustainable whaling according to scientific principles.
In Europe, obesity is to blame for around 6.5 percent of all new cancers a year, or around 65,000 cases
Medical workers risking their lives to fight Ebola in West Africa talk about the challenges they face.
The woman 32, died at a fever hospital in the Nile Delta five days after she was admitted on contracting the virus, Hossam Abdel-Ghafar said
According to the World Health Organization, more than 80,000 children in Pakistan have not been immunized against polio
A total of 5,459 people have died in the worst Ebola outbreak on record, according the World Health Organization
Plague, a bacterial disease, is mainly spread from one rodent to another by fleas.
Felix Baez Sarria, the first Cuban to contract the deadly disease, will be treated in a Geneva hospital.
No Ebola cases detected for two incubation periods, says World Health Organization
The World Health Organization and leading global health specialists have criticised Saudi Arabia for failing to properly investigate the causes of MERS.
UNICEF predicts that the number of children orphaned by Ebola – which currently stands at nearly 200 – will reach as many as 2,000
UN Article 82 could mean millions in additional costs for drilling companies.
The figures, through Nov. 16, represent a jump of 243 deaths and 732 cases since those issued last Friday, and cases continue to be under-reported, the WHO said in its latest update.
The infectious disease causes total paralysis in a matter of hours. It affects mainly children under five years of age.
The 30-year-old woman was from the province of Minya, south of Cairo. She died in a hospital in the southern city of Assiut